| Scott L Knappenberger, MD | |
|
9411 N Oak Trfy, Suite 202, Kansas City, MO 64155-2233 | |
| (816) 468-8820 | |
| (816) 468-8898 |
| Full Name | Scott L Knappenberger |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 23 Years |
| Location | 9411 N Oak Trfy, Kansas City, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770503484 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 2006020974 (Missouri) | Secondary |
| 207Y00000X | Otolaryngology | 0434839 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
| Meritas Health Corporation | 6305748153 | 365 |
| Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No. 6,264,981 (the '981 Patent). The Company said that it was reviewing the court's decision and would evaluate all available options, including an appeal.
Taking gold nanoparticles to the cancer cell and hitting them with a laser has been shown to be a promising tool in fighting cancer, but what about cancers that occur in places where a laser light can't reach? Scientists at the Georgia Institute of Technology have shown that by directing gold nanoparticles into the nuclei of cancer cells, they can not only prevent them from multiplying, but can kill them where they lurk. The research appeared as a communication in the February 10 edition of the Journal of the American Chemical Society.
Up to 45,000 sudden cardiac arrests occur each year in Canada, and less than five percent survive. In some of these cases, the event cannot be explained by the presence of underlying heart disease. In order to identify people at risk of these unexplained cardiac events, a newly published study examined the presence of certain warning symptoms that are present in people who have been resuscitated from a cardiac arrest.
Kaiser Health News reports on a new ad by a coalition that includes "the drug industry, physicians' lobby and some backers of President Barack Obama's health care overhaul argue that the changes Congress is considering will make the health care system more stable and affordable." The analysis finds that "the ad promises more certainty about the future than Congress is likely to be able to ensure" (Rau, 8/24).
› Verified 3 days ago
| Entity Name | Saint Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No. 6,264,981 (the '981 Patent). The Company said that it was reviewing the court's decision and would evaluate all available options, including an appeal.
Taking gold nanoparticles to the cancer cell and hitting them with a laser has been shown to be a promising tool in fighting cancer, but what about cancers that occur in places where a laser light can't reach? Scientists at the Georgia Institute of Technology have shown that by directing gold nanoparticles into the nuclei of cancer cells, they can not only prevent them from multiplying, but can kill them where they lurk. The research appeared as a communication in the February 10 edition of the Journal of the American Chemical Society.
Up to 45,000 sudden cardiac arrests occur each year in Canada, and less than five percent survive. In some of these cases, the event cannot be explained by the presence of underlying heart disease. In order to identify people at risk of these unexplained cardiac events, a newly published study examined the presence of certain warning symptoms that are present in people who have been resuscitated from a cardiac arrest.
Kaiser Health News reports on a new ad by a coalition that includes "the drug industry, physicians' lobby and some backers of President Barack Obama's health care overhaul argue that the changes Congress is considering will make the health care system more stable and affordable." The analysis finds that "the ad promises more certainty about the future than Congress is likely to be able to ensure" (Rau, 8/24).
› Verified 3 days ago
| Entity Name | Meritas Health Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801875091 PECOS PAC ID: 6305748153 Enrollment ID: O20040122001058 |
News Archive
Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No. 6,264,981 (the '981 Patent). The Company said that it was reviewing the court's decision and would evaluate all available options, including an appeal.
Taking gold nanoparticles to the cancer cell and hitting them with a laser has been shown to be a promising tool in fighting cancer, but what about cancers that occur in places where a laser light can't reach? Scientists at the Georgia Institute of Technology have shown that by directing gold nanoparticles into the nuclei of cancer cells, they can not only prevent them from multiplying, but can kill them where they lurk. The research appeared as a communication in the February 10 edition of the Journal of the American Chemical Society.
Up to 45,000 sudden cardiac arrests occur each year in Canada, and less than five percent survive. In some of these cases, the event cannot be explained by the presence of underlying heart disease. In order to identify people at risk of these unexplained cardiac events, a newly published study examined the presence of certain warning symptoms that are present in people who have been resuscitated from a cardiac arrest.
Kaiser Health News reports on a new ad by a coalition that includes "the drug industry, physicians' lobby and some backers of President Barack Obama's health care overhaul argue that the changes Congress is considering will make the health care system more stable and affordable." The analysis finds that "the ad promises more certainty about the future than Congress is likely to be able to ensure" (Rau, 8/24).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott L Knappenberger, MD 901 E 104th St, Mailstop 400s, Kansas City, MO 64131 Ph: (913) 317-3130 | Scott L Knappenberger, MD 9411 N Oak Trfy, Suite 202, Kansas City, MO 64155-2233 Ph: (816) 468-8820 |
News Archive
Watson Pharmaceuticals, Inc., today confirmed that the United States District Court for the District of Delaware has ruled that Watson's generic version of Fentora® (fentanyl buccal tablets C-II) infringes United States Patent No. 6,264,981 (the '981 Patent). The Company said that it was reviewing the court's decision and would evaluate all available options, including an appeal.
Taking gold nanoparticles to the cancer cell and hitting them with a laser has been shown to be a promising tool in fighting cancer, but what about cancers that occur in places where a laser light can't reach? Scientists at the Georgia Institute of Technology have shown that by directing gold nanoparticles into the nuclei of cancer cells, they can not only prevent them from multiplying, but can kill them where they lurk. The research appeared as a communication in the February 10 edition of the Journal of the American Chemical Society.
Up to 45,000 sudden cardiac arrests occur each year in Canada, and less than five percent survive. In some of these cases, the event cannot be explained by the presence of underlying heart disease. In order to identify people at risk of these unexplained cardiac events, a newly published study examined the presence of certain warning symptoms that are present in people who have been resuscitated from a cardiac arrest.
Kaiser Health News reports on a new ad by a coalition that includes "the drug industry, physicians' lobby and some backers of President Barack Obama's health care overhaul argue that the changes Congress is considering will make the health care system more stable and affordable." The analysis finds that "the ad promises more certainty about the future than Congress is likely to be able to ensure" (Rau, 8/24).
› Verified 3 days ago
Dr. Kim Ann Suk Baker, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3042 | |
Dr. Bart C Patenaude, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 15 E 54th St, Kansas City, MO 64110 Phone: 816-519-3013 | |
Dr. Ann Bailey Robinson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr, Suite 450, Kansas City, MO 64114 Phone: 816-942-7200 Fax: 816-941-2767 | |
Dr. Pamela Nicklaus, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Robert Weatherly, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Joseph R Guastello, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4320 Wornall Rd, Ste 512, Kansas City, MO 64111 Phone: 816-932-8663 | |
Dr. Thomas Cotton, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |